Â鶹´«Ã½¸ßÇå°æ

Rohit Chandwani, M.D., Ph.D. is an Assistant Professor in the Department of Surgery at NewYork-Presbyterian / Â鶹´«Ã½¸ßÇå°æ. A board-certified surgical oncologist, Dr. Chandwani is a surgeon in the Section of Liver Transplantation & Hepatopancreatobiliary Surgery with a specific clinical focus in pancreatic cancer and metastatic colorectal cancer. He also has significant clinical expertise in the care of patients with pancreatic cysts, pancreatic neuroendocrine tumors, and intrahepatic and extrahepatic cholangiocarcinoma.

Dr. Chandwani received his undergraduate degree from Harvard University in 2001 and earned his medical degree at the Yale University School of Medicine in 2005. He then trained in General Surgery at NewYork-Presbyterian / Columbia University Medical Center and in Complex General Surgical Oncology at Memorial Sloan Kettering Cancer Center, where he served as Chief Fellow for the Department of Surgery.

A surgeon-scientist, Dr. Chandwani is also the Principal Investigator of the Laboratory of Cancer Epigenetics at Weill Cornell Medical College, where he studies the epigenetic dysregulation of pancreatic cancer. Prior to his research at Cornell, Dr. Chandwani earned his Ph.D. from The Rockefeller University in the laboratory of Alexander Tarakhovsky and was a postdoctoral fellow in the laboratory of Steven D. Leach in the David M. Rubinstein Center for Pancreatic Cancer Research at Memorial Sloan Kettering Cancer Center. He has been the recipient of funding from the National Institutes of Health, the American Association for Cancer Research (AACR), and the Pancreatic Cancer Action Network for his ongoing research program into the epigenetic targeting of cancer. More information about his research can be found at .